A new antiviral could stop measles before an outbreak takes off

• A new drug called daraxonrasib has been shown to double survival rates for metastatic pancreatic cancer patients. • The drug reduces the risk of death by 60 percent for patients with previously treated metastatic pancreatic cancer, marking significant progress in treating the disease.

• A new study suggests that lifestyle modifications, including regular exercise and healthy eating, may slow the progression of metabolic dysfunction-associated steatotic liver disease (MASLD). • The research indicates that exercise and meal timing can protect the liver by switching off a harmful molecular pathway.

• Trust in key U.S. health agencies, including the NIH and FDA, has plummeted to all-time lows following the COVID-19 pandemic. • Confidence in the CDC's ability to perform its core responsibilities has dropped by nearly 40% since the start of the pandemic.

• On 28 April 2026, the Medicines and Healthcare products Regulatory Agency (MHRA) and the Health Research Authority introduced the most significant package of clinical trial reforms in over 20 years. • The legislative changes aim to accelerate the setup of low-risk trials and streamline the process for making modifications to existing studies.

• Merck is establishing voluntary licensing agreements to enable the wide-scale production of its experimental HIV prevention pill in lower-income countries. • The company is pursuing these partnerships while the drug is still undergoing two late-stage clinical trials to accelerate future availability.

• A diarrhea bug outbreak has expanded to four additional states, while Dr. Anthony Fauci is scheduled to testify before Congress. • In legislative developments, momentum is growing for the creation of a dedicated office of men's health within the Department of Health and Human Services (HHS).

• An FDA advisory committee voted to expand access to four peptides, including KPV, despite the agency's warnings regarding a lack of clinical evidence for their efficacy. • The FDA specifically noted that there is no human clinical data to support using KPV for wound healing or inflammatory conditions like psoriasis, eczema, and ulcerative colitis.

• A Washington Post investigation published July 24, 2026, reveals significant regulatory gaps in how U.S. states oversee medspas and the sale of peptide injections. • The report found that wellness clinics selling amino acid chains for weight loss and longevity often face less oversight and fewer inspections than local restaurants or hair salons.

• New York City health officials are currently investigating an outbreak of Legionnaires’ disease that has resulted in multiple deaths and dozens of illnesses. • Medical professionals are issuing guidance to the public on specific preventative measures to reduce the risk of exposure to the bacteria.

• Ipsen announced that its drug Bylvay failed to meet the primary objective in a late-stage clinical trial for biliary atresia, a rare liver disease in infants. • The study failed to demonstrate that Bylvay improved native liver survival rates when compared to a placebo.

• A multistate outbreak of Cyclospora has been linked to the consumption of iceberg lettuce across nine U.S. states. • Health officials are tracking cyclosporiasis cases and urging affected individuals to report symptoms to their local health departments.